Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo A Manfredi

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Seminars in Thrombosis and Hemostasis|September 27, 2015
Tissue Factor Expressed by Neutrophils: Another Piece in the Vascular Inflammation PuzzleNorma Maugeri, Angelo A Manfredi
Pharmacological Research|September 2, 2008
The immune system facing injured tissues and stem cells: more of a healer or a fighter?Emilio Clementi, Angelo A Manfredi
Journal of Thrombosis and Haemostasis : JTH|August 15, 2022
"Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19": ReplyNorma Maugeri, Angelo A Manfredi
Nature Reviews. Rheumatology|July 7, 2025
Platelets as drivers of immunothrombosis in rheumatic diseasesNorma Maugeri, Angelo A Manfredi
Journal of Thrombosis and Haemostasis : JTH|August 22, 2024
Platelet HMGB1 steers intravascular immunity and thrombosisNorma Maugeri, Angelo A Manfredi
The New England Journal of Medicine|June 4, 2010
The mitochondrion--a Trojan horse that kicks off inflammation?Angelo A Manfredi, Patrizia Rovere-Querini
JOP : Journal of the Pancreas|July 16, 2004
Tumor destruction and in situ delivery of antigen presenting cells promote anti-neoplastic immune responses: implications for the immunotherapy of pancreatic cancerPatrizia Rovere-Querini, Angelo A Manfredi
International Journal of Cardiology|March 27, 2018
The saga of atherothrombosis and T-cells: Looking for the lost prologueGiuseppe A Ramirez, Angelo A Manfredi
Immunological Reviews|November 6, 2007
High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunityMarco E Bianchi, Angelo A Manfredi
Science (New York, N.Y.)|March 28, 2009
Immunology. Dangers in and outMarco E Bianchi, Angelo A Manfredi
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Seminars in Thrombosis and Hemostasis|September 27, 2015
Tissue Factor Expressed by Neutrophils: Another Piece in the Vascular Inflammation PuzzleNorma Maugeri, Angelo A Manfredi
Pharmacological Research|September 2, 2008
The immune system facing injured tissues and stem cells: more of a healer or a fighter?Emilio Clementi, Angelo A Manfredi
Journal of Thrombosis and Haemostasis : JTH|August 15, 2022
"Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19": ReplyNorma Maugeri, Angelo A Manfredi
Nature Reviews. Rheumatology|July 7, 2025
Platelets as drivers of immunothrombosis in rheumatic diseasesNorma Maugeri, Angelo A Manfredi
Journal of Thrombosis and Haemostasis : JTH|August 22, 2024
Platelet HMGB1 steers intravascular immunity and thrombosisNorma Maugeri, Angelo A Manfredi
The New England Journal of Medicine|June 4, 2010
The mitochondrion--a Trojan horse that kicks off inflammation?Angelo A Manfredi, Patrizia Rovere-Querini
JOP : Journal of the Pancreas|July 16, 2004
Tumor destruction and in situ delivery of antigen presenting cells promote anti-neoplastic immune responses: implications for the immunotherapy of pancreatic cancerPatrizia Rovere-Querini, Angelo A Manfredi
International Journal of Cardiology|March 27, 2018
The saga of atherothrombosis and T-cells: Looking for the lost prologueGiuseppe A Ramirez, Angelo A Manfredi
Immunological Reviews|November 6, 2007
High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunityMarco E Bianchi, Angelo A Manfredi
Science (New York, N.Y.)|March 28, 2009
Immunology. Dangers in and outMarco E Bianchi, Angelo A Manfredi
Pageof 18